Literature DB >> 12160478

A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.

Michiko Tsuneizumi1, Hisaki Nagai, Haruhito Harada, Teruhisa Kazui, Mitsuu Emi.   

Abstract

BACKGROUND: Cloning of CpG binding sites in the human genome initially identified EBAG9 (estrogen receptor-binding fragment-associated gene 9), an estrogen-responsive gene mapped to chromosome 8q23. Its product was later found to be identical to RCAS1 (receptor-binding cancer antigen expressed on SiSo cells 1). RCAS1 was recently described as a cancer-surface antigen, implicated in immune escape in a human uterine adenocarcinoma cell line, which turned out to be identical to the EBAG9 molecule. AIM: The study seeks to isolate a highly polymorphic dinucleotide repeat at this locus that detects frequent multiplication of the EBAG9/RCAS1 gene. SUBJECT AND METHODS: A fragment containing CA repeat was identified by Southern blotting of bacterial artificial chromosome (BAC) clone containing the EBAG9/RCAS1 gene digested by Hae III, Sau 3A or Rsa I with (GT)20 probe, subcloned and sequenced.
RESULTS: We isolated a polymorphic dinucleotide (CA) repeat sequence from a genomic clone containing the EBAG9/RCAS1 gene located at 8q23. High heterozygosity (0.859) makes this polymorphism a useful marker in genetic studies. This marker detected frequent multiplication of the EBAG9/RCAS1 gene in primary breast cancers (27 of 129 tumours).
CONCLUSION: This marker is useful for detecting frequent multiplication of the EBAG9/RCAS1 gene in primary breast cancers and other cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160478     DOI: 10.1080/03014460110087762

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  3 in total

1.  Novel serum tumor marker, RCAS1, in pancreatic diseases.

Authors:  Koji Yamaguchi; Munechika Enjoji; Manabu Nakashima; Makoto Nakamuta; Takashi Watanabe; Masao Tanaka
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

2.  Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice.

Authors:  Yoshiki Naito; Yoshinobu Okabe; Masakatsu Nagayama; Takuya Nishinakagawa; Tomoki Taira; Akihiko Kawahara; Satoshi Hattori; Kazuyuki Machida; Yusuke Ishida; Ryohei Kaji; Kazuhiro Mikagi; Hisafumi Kinoshita; Makiko Yasumoto; Jun Akiba; Masayoshi Kage; Manabu Nakashima; Koichi Ohshima; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2011-06-30       Impact factor: 2.309

3.  The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration.

Authors:  Magdalena Dutsch-Wicherek; Romana Tomaszewska; Pawel Strek; Lukasz Wicherek; Jacek Skladzien
Journal:  BMC Immunol       Date:  2006-03-21       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.